At a Glance
Orgovyx (relugolix) is FDA‑approved to treat adult men with advanced prostate cancer.
This is a brand drug with no generic or biosimilar.
Active ingredient: Relugolix.
Administration route: Oral.
The usual Orgovyx dose is 360 mg by mouth once on day 1, followed by 120 mg taken once daily thereafter.
How It Works
- Orgovyx blocks a hormone signal from the brain (GnRH) that normally tells the testes to make testosterone.
- By lowering testosterone to very low levels, it helps slow or stop the growth of prostate cancer cells that depend on testosterone.
- It is taken by mouth each day and works as a form of medical (chemical) castration instead of surgery.
Treatment and Efficacy
Approved indications
Orgovyx is FDA‑approved for the treatment of adult patients with advanced (including metastatic or recurrent) prostate cancer who need androgen‑deprivation therapy.
Off‑label uses
There are no widely accepted, well‑studied off‑label uses in the United States; its use is largely limited to its approved indication.
Efficacy expectations
Testosterone levels typically fall into the medical castration range within about 1 week of starting therapy, and PSA levels usually begin to decline over the following weeks to months. In clinical trials, Orgovyx maintained medical castration in the vast majority of patients over 48 weeks and showed non‑inferior, and in some measures superior, rapid testosterone suppression compared with leuprolide. When Orgovyx is stopped, testosterone levels generally recover faster than with many injectable GnRH agonists, which may be useful when treatment breaks are planned.
Dosage and Administration
Typical dosing and how to take
The standard regimen for adults with advanced prostate cancer is 360 mg by mouth once on day 1, then 120 mg by mouth once daily starting on day 2. Tablets are swallowed whole with or without food at about the same time each day.
Special dosing instructions
No loading dose is repeated after day 1. Dose adjustments or extra monitoring may be needed when Orgovyx is given with certain strong P‑gp or CYP3A inducers or inhibitors, or in severe kidney or liver impairment, as directed by a clinician.
Missed dose
If a dose is missed and it is within 12 hours of the usual time, take it as soon as remembered; if more than 12 hours have passed, skip the missed dose and take the next dose at the regular time without doubling.
Overdose
In case of suspected overdose, contact a poison control center or seek emergency medical care right away, bringing the medication bottle if possible.
Safety and Side Effects
Common side effects
Frequently reported effects include hot flashes, fatigue, musculoskeletal pain, constipation or diarrhea, and mild liver enzyme elevations; these are often mild to moderate and can appear within days to weeks after starting treatment.
Serious or rare adverse effects
Serious risks include heart rhythm problems (QT prolongation), increased risk of blood clots or cardiovascular events, severe liver injury (rare), and severe allergic reactions with swelling or trouble breathing. Sudden chest pain, shortness of breath, fainting, severe dizziness, or yellowing of the skin or eyes require immediate medical attention.
Warnings and precautions
Orgovyx is not indicated for use in women or children; exposure in pregnancy can harm a fetus, so pregnant women should avoid handling crushed or broken tablets. Caution is advised in patients with significant liver impairment or a history of heart rhythm disorders, recent heart attack, or stroke. Kidney problems usually do not require dose adjustment unless severe, but clinicians may individualize therapy.
Comparative safety
Compared with some injectable GnRH agonists, Orgovyx may have a lower observed rate of major cardiovascular events in high‑risk patients, but monitoring for heart and metabolic effects remains important for all androgen‑deprivation therapies.
Reporting and safety updates
Patients and caregivers in the United States can report side effects to the FDA’s MedWatch program or to the manufacturer, and prescribers can check FDA drug safety communications for any new warnings.
Interactions and Precautions
Drug and supplement interactions
Orgovyx is affected by strong P‑gp and CYP3A inducers (such as rifampin, carbamazepine, phenytoin, St. John’s wort), which can lower its levels, and by strong P‑gp inhibitors (such as certain antivirals or antifungals), which can raise its levels; dose timing or choice of alternative medicines may be needed. It may also affect other drugs that are P‑gp substrates. Always review all prescription medicines, OTC products, vitamins, and herbal supplements with a healthcare provider.
Food, alcohol, and procedures
Food does not significantly affect Orgovyx exposure, so it can be taken with or without meals. Moderate alcohol use is not specifically contraindicated but should be discussed, especially in patients with liver disease or cardiovascular risk. No specific interactions with diagnostic imaging agents are known, but clinicians should be aware the drug induces medical castration, which may influence interpretation of hormone‑sensitive tests.
Precautions and monitoring
Caution is required in patients with a history of heart disease, arrhythmias, stroke, or uncontrolled risk factors such as hypertension or diabetes. Baseline and periodic monitoring may include testosterone and PSA levels, liver function tests, and, in higher‑risk patients, ECGs and cardiovascular assessment. Bone health monitoring (for example, bone density) may be recommended with long‑term androgen‑deprivation therapy.
Common Questions and Answers
Q: How long does it take for Orgovyx to start lowering testosterone?
A: Testosterone usually falls into the castration range within about 1 week of starting Orgovyx, although symptom improvement such as pain relief may take longer.
Q: Can I stop Orgovyx once my PSA goes down?
A: Do not stop or change your dose without your cancer specialist’s guidance; decisions about stopping or taking breaks from therapy depend on your cancer stage, treatment plan, and how you are responding.
Q: Do I need to take Orgovyx with food?
A: No, you can take Orgovyx with or without food, but try to take it at the same time each day to help you remember.
Q: What should I do if I vomit after taking a dose?
A: If you vomit shortly after a dose, do not take an extra tablet; wait until your next scheduled dose and contact your healthcare team if vomiting continues or you are unsure.
Q: Is Orgovyx safer for the heart than injectable hormone shots?
A: In clinical studies, men at high cardiovascular risk had fewer major heart‑related events on Orgovyx than on leuprolide, but heart risks are not eliminated, so ongoing cardiovascular monitoring and risk‑factor management remain important.
Better Treatment, Lower Cost – No Catch.
Find safer, more effective medications with fewer side effects – often for less money. It’s fast, free, and personalized. Learn More →
Disposal Guidance
Storage
Store Orgovyx tablets at room temperature, tightly closed in the original bottle, away from moisture and out of reach of children and pets.
Disposal
Do not flush unused tablets down the toilet unless instructed; use a drug take‑back program if available, or follow local guidelines for disposing of prescription medicines in household trash (for example, mixing with undesirable material in a sealed container).